Abstract:Medicalisation is a pervasive feature of contemporary end of life and dying in Western Europe and North America. In this article, we focus on the relationship between two specific aspects of the medicalisation of dying: deep continuous palliative sedation until death and assisted dying. We draw upon a qualitative interview study with 29 health professionals from three jurisdictions where assisted dying is lawful: Flanders, Belgium; Oregon, USA; and Quebec, Canada. Our findings demonstrate that the relationship… Show more
“…45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA). 45 The researchers argue that, to a significant degree, this may be related to the fact that assisted dying in Oregon can be self-administered, occurring mostly without the involvement of health professionals beyond lethal prescribing. On the other hand, physicians' involvement with assisted death in Quebec and Flanders is “practical” and continues until death.…”
Section: Discussionmentioning
confidence: 95%
“…On the other hand, physicians' involvement with assisted death in Quebec and Flanders is “practical” and continues until death. 45 The authors conclude that, regardless of the country where the participants were interviewed, the relief of suffering emerges as a concept- key in both PS and assisted death, however, both interventions can also be perceived as a way to exacerbate suffering. 45 It is important to note that, according to the European Association for Palliative Care, “in terminal sedation the intention is to relieve intolerable suffering, the procedure is to use a sedating drug for symptom control and the successful outcome is the alleviation of distress.…”
Section: Discussionmentioning
confidence: 97%
“…44 Despite theoretical attempts to separate these practices, PS and assisted death have been shown to be intertwined in practice. 45 A study was carried out with the objective of investigating the relationship between 2 specific aspects of the medicalization of dying: continuous and deep PS until death, and assisted dying in cities in 3 different countries (Belgium, USA and Canada). 45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA).…”
Section: Discussionmentioning
confidence: 99%
“…45 A study was carried out with the objective of investigating the relationship between 2 specific aspects of the medicalization of dying: continuous and deep PS until death, and assisted dying in cities in 3 different countries (Belgium, USA and Canada). 45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA). 45 The researchers argue that, to a significant degree, this may be related to the fact that assisted dying in Oregon can be self-administered, occurring mostly without the involvement of health professionals beyond lethal prescribing.…”
Palliative Sedation (PS) is an effective measure for the relief of refractory symptoms in end-of-life patients. This intervention can be performed at home, respecting the patients' and their families' decisions. A scoping review was performed to map the available evidence in the literature on the performance of PS at home. This review included 23 studies. Most were conducted in European countries with adult cancer patients. Patients, family members and healthcare providers participated in the decision making regarding the use of PS at home. PS was used primarily to manage refractory symptoms (pain, delirium, dyspnea, and others), and in 1 of the studies PS was mentioned as a possible intervention for shortening life. The most commonly used medication was midazolam and the average duration ranged from 4 h to 7 days. There are few reports on adverse events related to PS. This intervention seems to be a feasible possibility for the management of refractory symptoms in patients at the end of life, despite the fact that it can represent specific challenges for healthcare providers, patients and families. However, the literature is limited regarding PS in children and in people with diseases other than cancer, as well as on the evaluation of possible adverse effects related to this intervention. Furthermore, it is essential to have a broad ethical, clinical and legal debate on whether to consider the use of PS for the purpose of shortening life in specific cases.
“…45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA). 45 The researchers argue that, to a significant degree, this may be related to the fact that assisted dying in Oregon can be self-administered, occurring mostly without the involvement of health professionals beyond lethal prescribing. On the other hand, physicians' involvement with assisted death in Quebec and Flanders is “practical” and continues until death.…”
Section: Discussionmentioning
confidence: 95%
“…On the other hand, physicians' involvement with assisted death in Quebec and Flanders is “practical” and continues until death. 45 The authors conclude that, regardless of the country where the participants were interviewed, the relief of suffering emerges as a concept- key in both PS and assisted death, however, both interventions can also be perceived as a way to exacerbate suffering. 45 It is important to note that, according to the European Association for Palliative Care, “in terminal sedation the intention is to relieve intolerable suffering, the procedure is to use a sedating drug for symptom control and the successful outcome is the alleviation of distress.…”
Section: Discussionmentioning
confidence: 97%
“…44 Despite theoretical attempts to separate these practices, PS and assisted death have been shown to be intertwined in practice. 45 A study was carried out with the objective of investigating the relationship between 2 specific aspects of the medicalization of dying: continuous and deep PS until death, and assisted dying in cities in 3 different countries (Belgium, USA and Canada). 45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA).…”
Section: Discussionmentioning
confidence: 99%
“…45 A study was carried out with the objective of investigating the relationship between 2 specific aspects of the medicalization of dying: continuous and deep PS until death, and assisted dying in cities in 3 different countries (Belgium, USA and Canada). 45 The results indicated that PS is sometimes perceived as something belonging to the sphere of assisted dying, but probably more so in Quebec (Canada) and Flanders (Belgium) than in Oregon (USA). 45 The researchers argue that, to a significant degree, this may be related to the fact that assisted dying in Oregon can be self-administered, occurring mostly without the involvement of health professionals beyond lethal prescribing.…”
Palliative Sedation (PS) is an effective measure for the relief of refractory symptoms in end-of-life patients. This intervention can be performed at home, respecting the patients' and their families' decisions. A scoping review was performed to map the available evidence in the literature on the performance of PS at home. This review included 23 studies. Most were conducted in European countries with adult cancer patients. Patients, family members and healthcare providers participated in the decision making regarding the use of PS at home. PS was used primarily to manage refractory symptoms (pain, delirium, dyspnea, and others), and in 1 of the studies PS was mentioned as a possible intervention for shortening life. The most commonly used medication was midazolam and the average duration ranged from 4 h to 7 days. There are few reports on adverse events related to PS. This intervention seems to be a feasible possibility for the management of refractory symptoms in patients at the end of life, despite the fact that it can represent specific challenges for healthcare providers, patients and families. However, the literature is limited regarding PS in children and in people with diseases other than cancer, as well as on the evaluation of possible adverse effects related to this intervention. Furthermore, it is essential to have a broad ethical, clinical and legal debate on whether to consider the use of PS for the purpose of shortening life in specific cases.
“…Bereaved study participants in Ireland spoke of the vigil as a significant time of farewell, through '…its reciprocity or mutuality', suggesting its importance to all parties (Donnelly & Battley, 2010: 98). Dying is often described as medicalised, with professional institutions and practitioners having an over-influential role in decision making and orchestrating the end of life (Koksvik et al, 2020). The vigil is one possible way of attempting to reclaim dying on behalf of both the family and the dying person, and as a way of affirming bonds in readiness for the post-death period (Valentine, 2007).…”
This paper explores how people enact and experience the deathbed vigil when someone close to them is dying. It draws on qualitative interviews with 34 bereaved people carried out as part of a wider study exploring public perceptions of death and dying. Participants were aware of the expectation that they would attend the deathbed and did their best to do so. Findings are reported using four themes: gathering, enacting the deathbed vigil, experiencing the deathbed vigil and moment of death. Participants’ experiences varied. Some families kept vigil as a group, while others established a shift system or waited alone. Activities at the bedside included reading to the dying person, talking amongst themselves, sharing memories, saying goodbye. The covid-19 pandemic highlighted families’ wish to accompany their dying relatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.